Trial Profile
Clinical efficacy in the budesonide / folmoterol for the COPD patients under using tiotropium.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2013
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 03 Sep 2013 New trial record